Cargando…
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
Kynurenine-3-monooxygenase (KMO) is a key FAD-dependent enzyme of tryptophan metabolism. In animal models, KMO inhibition has shown benefit in neurodegenerative diseases such as Huntington's and Alzheimer's. Most recently it has been identified as a target for acute pancreatitis multiple o...
Autores principales: | Hutchinson, Jonathan P., Rowland, Paul, Taylor, Mark R. D., Christodoulou, Erica M., Haslam, Carl, Hobbs, Clare I., Holmes, Duncan S., Homes, Paul, Liddle, John, Mole, Damian J., Uings, Iain, Walker, Ann L., Webster, Scott P., Mowat, Christopher G., Chung, Chun-wa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477544/ https://www.ncbi.nlm.nih.gov/pubmed/28604669 http://dx.doi.org/10.1038/ncomms15827 |
Ejemplares similares
-
Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016) -
Diclofenac Identified as a Kynurenine 3-Monooxygenase
Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018) -
Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019) -
Structural basis of kynurenine 3-monooxygenase inhibition
por: Amaral, Marta, et al.
Publicado: (2013) -
Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
por: Wilson, K., et al.
Publicado: (2014)